The association between C-159T polymorphism in CD14 gene and susceptibility to tuberculosis: a meta-analysis

Molecular Biology Reports

Volumn 41, Issue 11, 2014, Pages 7623-7629

  Yuan, Qing ^a   Chen, Huifang ^a,b   Zheng, Xueyan ^b   Chen, Xiaming ^a   Li, Qun ^a   Zhang, Yanping ^a   Zhang, Xiaorong ^a   Shi, Tingli ^b   Zhou, Junhua ^b   Chen, Qing ^b   Yu, Shouyi ^b  

^a Songgang Health Inspection and Prevention Institute   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

CD14; Meta analysis; Polymorphism; Tuberculosis

Indexed keywords

ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CD14 GENE; DISEASE CARRIER; ETHNICITY; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TUBERCULOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

CD14 ANTIGEN;

ANTIGENS, CD14; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULOSIS;

EID: 84917736613     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3652-1     Document Type: Article

References (47)

1. The Lancet (2012) Tuberculosis control and elimination in 2012 and beyond. Lancet 2012, 379:1076
2. Lawn SD, Zumla AI (2011) Tuberculosis. Lancet 378:57–72
3. WHO (2012) Global tuberculosis report 2012
4. Druszczynska M, Kowalewicz-Kulbat M, Fol M, Wlodarczyk M, Rudnicka W (2012) Latent M. tuberculosis infection–pathogenesis, diagnosis, treatment and prevention strategies. Pol J Microbiol 61:3–10
5. Ernst JD (2012) The immunological life cycle of tuberculosis. Nat Rev Immunol 12:581–591
6. Axelsson-Robertson R, Magalhaes I, Parida SK, Zumla A, Maeurer M (2012) The immunological footprint of Mycobacterium tuberculosis T-cell epitope recognition. J Infect Dis 205(Suppl 2):S301–S315
7. Azad AK, Sadee W, Schlesinger LS (2012) Innate immune gene polymorphisms in tuberculosis. Infect Immun 80:3343–3359
8. Alagarasu K, Selvaraj P, Swaminathan S, Raghavan S, Narendran G (2009) Narayanan PR: CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms in HIV-1 infected patients with & without tuberculosis. Indian J Med Res 130:444–450
9. Bahari G, Hashemi M, Taheri M, Naderi M, Eskandari-Nasab E, Atabaki M (2012) Association of IRGM polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan Southeast Iran. Sci World J 2012:950801
10. Baker AR, Qiu F, Randhawa AK, Horne DJ, Adams MD, Shey M, Barnholtz-Sloan J, Mayanja-Kizza H, Kaplan G, Hanekom WA et al (2012) Genetic variation in TLR genes in Ugandan and South African populations and comparison with HapMap data. PLoS One 7:e47597
11. Ben-Selma W, Ben-Kahla I, Boukadida J, Harizi H (2011) Contribution of the P2X7 1513A/C loss-of-function polymorphism to extrapulmonary tuberculosis susceptibility in Tunisian populations. FEMS Immunol Med Microbiol 63:65–72
12. Hanta I, Tastemir-Korkmaz D, Demirhan O, Hanta D, Kuleci S, Seydaoglu G (2012) Association of the Nramp1 gene polymorphisms and clinical forms in patients with tuberculosis. Bratisl Lek Listy 113:657–660
13. Mishra G, Poojary SS, Raj P, Tiwari PK (2012) Genetic polymorphisms of CCL2, CCL5, CCR2 and CCR5 genes in Sahariya tribe of North Central India: an association study with pulmonary tuberculosis. Infect Genet Evol 12:1120–1127
14. Peng R, Yue J, Han M, Zhao Y, Liu L, Liang L (2012) The IL-17F sequence variant is associated with susceptibility to tuberculosis. Gene 515:229–232
15. Pydi SS, Sunder SR, Venkatasubramanian S, Kovvali S, Jonnalagada S, Valluri VL (2013) Killer cell immunoglobulin like receptor gene association with tuberculosis. Hum Immunol 74:85–92
16. Zhang G, Zhou B, Wang W, Zhang M, Zhao Y, Wang Z, Yang L, Zhai J, Feng CG, Wang J, Chen X (2012) A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis 205:1697–1704
17. Alavi-Naini R, Salimi S, Sharifi-Mood B, Davoodikia AA, Moody B, Naghavi A (2012) Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis. Int J Tuberc Lung Dis 16:1383–1387
18. Ayaslioglu E, Kalpaklioglu F, Kavut AB, Erturk A, Capan N, Birben E (2012) The role of CD14 gene promoter polymorphism in tuberculosis susceptibility. J Microbiol Immunol Infect 46:158–163
19. Xue Y, Zhao ZQ, Chen F, Zhang L, Li GD, Ma KW, Bai XF, Zuo YJ (2012) Polymorphisms in the promoter of the CD14 gene and their associations with susceptibility to pulmonary tuberculosis. Tissue Antigens 80:437–443
20. Zhao MY, Xue Y, Zhao ZQ, Li FJ, Fan DP, Wei LL, Sun XJ, Zhang X, Wang XC, Zhang YX, Li JC (2012) Association of CD14 G(-1145)A and C(-159)T polymorphisms with reduced risk for tuberculosis in a Chinese Han population. Genet Mol Res 11:3425–3431
21. Kang YA, Lee HW, Kim YW, Han SK, Shim YS, Yim JJ (2009) Association between the −159C/T CD14 gene polymorphism and tuberculosis in a Korean population. FEMS Immunol Med Microbiol 57:229–235
22. Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY (2007) CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis 196:1698–1706
23. Druszczynska M, Strapagiel D, Kwiatkowska S, Kowalewicz-Kulbat M, Rozalska B, Chmiela M, Rudnicka W (2006) Tuberculosis bacilli still posing a threat. Polymorphism of genes regulating anti-mycobacterial properties of macrophages. Pol J Microbiol 55:7–12
24. Pacheco E, Fonseca C, Montes C, Zabaleta J (2004) Garcia LF, Arias MA: CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol Med Microbiol 40:207–213
25. Rigoli L, Briuglia S, Caimmi S, Ferrau V, Gallizzi R, Leonardi S, La Rosa M, Salpietro C (2011) Gene-environment interaction in childhood asthma. Int J Immunopathol Pharmacol 24:41–47
26. Tesse R, Pandey RC, Kabesch M (2011) Genetic variations in toll-like receptor pathway genes influence asthma and atopy. Allergy 66:307–316
27. Waterer GW, Bruns AH (2010) Genetic risk of acute pulmonary infections and sepsis. Expert Rev Respir Med 4:229–238
28. Martinez FD (2007) CD14, endotoxin, and asthma risk: actions and interactions. Proc Am Thorac Soc 4:221–225
29. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD (1999) A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20:976–983
30. Davey SG, Egger M (1997) Meta-analyses of randomised controlled trials. Lancet 350:1182
31. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
32. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
33. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335–371
34. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
35. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
36. Strapagiel D, Kasztalska K, Druszczynska M, Kowalewicz-Kulbat M, Vrba A, Matusiak A, Chmiela M, Rudnicka W (2008) Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin. Folia Histochem Cytobiol 46:353–359
37. Tekin D, Kayaalti Z, Dalgic N, Cakir E, Soylemezoglu T, Isin KB, Aydin KB (2010) Polymorphism in the p2x7 gene increases susceptibility to extrapulmonary tuberculosis in Turkish children. Pediatr Infect Dis J 29:779–782
38. Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, Howson JM, Shaw MA, Burgner D, Xu W, Lins-Lainson Z et al (2004) Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 5:46–57
39. Lawn SD, Labeta MO, Arias M, Acheampong JW, Griffin GE (2000) Elevated serum concentrations of soluble CD14 in HIV- and HIV + patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin Exp Immunol 120:483–487
40. Yazdani N, Amoli MM, Naraghi M, Mersaghian A, Firouzi F, Sayyahpour F, Mokhtari Z (2012) Association between the functional polymorphism C-159T in the CD14 promoter gene and nasal polyposis: potential role in asthma. J Investig Allergol Clin Immunol 22:406–411
41. Loo WT, Bai LJ, Fan CB, Yue Y, Dou YD, Wang M, Liang H, Cheung MN, Chow L, Li JL et al (2012) Clinical application of human beta-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammation. J Transl Med 10(Suppl 1):S9
42. Kurne A, Sayat G, Aydin OF, Turgutoglu N, Terzi M, Sackesen C, Karabulut E, Karabudak R (2012) Lack of association of the CD14/C – 159T polymorphism with susceptibility and progression parameters in Turkish multiple sclerosis patients. J Neuroimmunol 250:83–86
43. Kim EJ, Chung WC, Lee KM, Paik CN, Jung SH, Lee BI, Chae HS, Choi KY (2012) Association between toll-like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population. J Korean Med Sci 27:72–77
44. Wu SQ, Zhang KB, Chen HQ, Zhao ZG, Wang GL, Chen C (2011) Association between gene polymorphism of CD14-159 (C/T) and allergic asthma. Mol Med Report 4:1127–1130
45. Ertan P, Berdeli A, Yilmaz O, Gonulal DA, Yuksel H (2011) LY96, UPKIB mutations and TLR4, CD14, MBL polymorphisms in children with urinary tract infection. Indian J Pediatr 78:1229–1233
46. Penders J, Thijs C, Mommers M, Stobberingh EE, Dompeling E, Reijmerink NE, van den Brandt PA, Kerkhof M, Koppelman GH, Postma DS (2010) Host-microbial interactions in childhood atopy: toll-like receptor 4 (TLR4), CD14, and fecal Escherichia coli. J Allergy Clin Immunol 125:231–236
47. Lin J, Yao YM, Huang ZH, Yu Y, Zhu JM, Chai JK, Sheng ZY (2006) The influence of CD14 genomic polymorphism on CD14 gene expression as well as protein release and its clinical significance in patients with extensive burns. Zhonghua Wai Ke Za Zhi 44:907–910